https://www.marketscreener.com/quote/stock/GILEAD-SCIENCES-INC-4876/news/FDA-Approves-Veklury-Remdesivir-for-the-Treatment-of-Non-Hospitalized-Patients-at-High-Risk-for-37612869/?utm_source=telegram&utm_medium=social&utm_campaign=share